Clinical Trials Browser

Phase 2 × Lymphoma × Drugs, Investigational × Clear all

NCT05972720 2025-05-15

FIRCE-1

Phase 2 Terminated

Lymphoma, Lymphoma, Non-Hodgkin, Neoplasms, Recurrence, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT04111107 2024-07-03

Precision Medicine for Patients With Identified Actionable Mutations

Phase 2 Terminated

45 enrolled 13 charts

LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Neoplasms